Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Mantle Cell Lymphoma

Ginger Wildheart diagnosed with "rare but aggressive" type of cancer, Mantle Cell Lymphoma

"Ginger wants everyone to know that strength and positivity will prevail, and the show will go on"

Louder · Mar 16

Fury over decision to axe ‘last hope’ cancer treatment from NHS

It’s being called a ‘backward step for NHS care’

The Independent UK · Feb 2

Charities launch appeal to reverse Nice decision on life-saving cancer treatment

Blood Cancer UK, Lymphoma Action and stem cell charity Anthony Nolan have formally appealed against the decision.

Evening Standard · Feb 2

From analysis to the latest developments in health,
read the most diverse news in one place.

BeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma Patients

BeOne Medicines Ltd. (NASDAQ:ONC) (formerly BeiGene) on Friday released topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, an investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase inhibitor (BTKi) and anti-CD20 therapy.

Benzinga · Aug 29, 2025

What is mantle cell lymphoma? Magda Szubanski’s ‘rare and fast-moving’ cancer, explained

Beloved Australian actor, Magda Szubanski, has revealed she’s been diagnosed with a “very rare, very aggressive, very serious” blood cancer called mantle cell lymphoma.

The Conversation · May 30, 2025

Kylie Minogue and Richard E Grant send ‘love’ to actress with stage 4 cancer

Magda Szubanski , who starred in Babe, gas been diagnosed with stage four mantle cell lymphoma.

Evening Standard · May 29, 2025

HC Wainwright Sees This Small-Cap Biotech As Undervalued, Underappreciated

At the European Hematology Association (EHA) meeting, Oncternal Therapeutics Inc (NASDAQ:ONCT) presented initial preclinical results of Oncternal's ROR1 CAR containing the antigen-binding region of zilovertamab. The data showed that The ROR1 CAR mediated target recognition and cell activation when expressed in either T cells or NK cells. Also, ROR1 CAR-T cells demonstrated dose-dependent anti-tumor…

Benzinga · Jun 13, 2022

Read news from The Economist, FT, and more,
with one subscription

Johnson & Johnson-AbbVie Partnered Lymphoma Drug Slows Disease Progression, Data Shows

Johnson & Johnson (NYSE:JNJ) and AbbVie Inc (NYSE:ABBV) announced primary results from the Phase 3 SHINE study of Imbruvica (ibrutinib) plus bendamustine-rituximab (BR) and rituximab maintenance in older patients with newly diagnosed mantle cell lymphoma (MCL). The combination regime significantly reduced the risk of disease progression or death by 25% compared to placebo plus BR…

Benzinga · Jun 6, 2022

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.